Predicting the emergence of drug-resistant HSV-2: New predictions

BMC Infectious Diseases

Volumn 3, Issue , 2003, Pages

  Gershengorn, Hayley B ^a   Darby, Graham ^b   Blower, Sally M ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DRUG USE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; IMMUNOCOMPETENCE; MATHEMATICAL MODEL; PREDICTION; PREVALENCE; STRAIN DIFFERENCE; THEORY; TIME; VIRUS ATTENUATION; VIRUS INFECTIVITY; VIRUS REACTIVATION; VIRUS SHEDDING; VIRUS STRAIN; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MODELS, BIOLOGICAL;

EID: 2442662922     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-3-1     Document Type: Article

References (15)

1. Blower SM, Porco TC and Darby G Predicting and preventing the emergence of antiviral drug resistance in HSV-2 Nature Medicine 1998, 4:673-678
2. Gershengorn HB and Blower SM The impact of antivirals & the emergence of drug resistance: HSV-2 epidemic control AIDS Patient Care & STDs 2000, 14(3):133-142
3. Blower SM, Gershengorn H and Grant R A Tale of Two Futures: HIV and antiretroviral therapy in San Francisco Science 2000, 287:650-654
4. Blower SM, Aschenbach AN, Gershengorn HB and Kahn JO Predicting the unpredictable: transmission of drug-resistant HIV Nature Medicine 2001, 7(9):1016-1020
5. Velasco-Hernandez JX, Gershengorn HB and Blower SM Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? The Lancet Infectious Diseases 2002, 2(8):487-493
6. Blower SM, Aschenbach AN and Kahn JO Predicting the transmission of drug-resistant HIV: comparing theory and data The Lancet Infectious Diseases 2003, 3(1):10-11
7. Collins P and Darby G Laboratory studies of herpes simplex virus strains resistant to acyclovir Reviews in Medical Virology 1991, 1:19-28
8. Field HJ Herpes simplex virus antiviral drug resistance - current trends and future prospects Journal of Clinical Virology 2001, 21:261-269
9. Morfin F and Thouvenot D Herpes simplex virus resistance to antiviral drugs Journal of Clinical Virology 2003, 26(1):29-37
10. Efstathiou S, Kemp S, Darby G and Minson AC The role of herpes simplex virus type 1 thymidine kinase in pathogenesis Journal of General Virology 1989, 70:869-879
11. Blower SM and Dowlatabadi H Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example International Statistics Review 1994, 2:229-243
12. Blower SM, McLean AR, Porco T, Sanchez M, Small PM, Hopewell P and Moss A The intrinsic transmission dynamics of tuberculosis epidemics Nature Medicine 1995, 1(8):815-821
13. Lietman T, Porco TC, Dawson C and Blower SM Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nature Medicine 1999, 5:572-576
14. Bacon TH, Levin MJ, Leary JJ, Sarisky RT and Sutton D Herpes simplex virus resistance to acyclovir and peniciclovir after two decades of antiviral therapy Clin Microbiol Rev 2003, 16(1):114-28
15. Blower SM and Volberding P What can modeling tell us about the threat of antiviral drug resistance? Current Opinion in Infectious Diseases 2002, 15(6):609-614